The 2026 ASCO Annual Meeting will be held from May 28 to June 2, 2026. The full text of the abstract and poster will be available on June 1, 2026, the day of the presentation.
Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with ...
-- PanGIA Analysis System, a novel machine learning platform for non-invasive diagnosis of oral cancer through an oral sample -- PanGIA Analysis System, a novel machine learning platform for ...
THE WOODLANDS, TX, April 08, 2026 (GLOBE NEWSWIRE)-- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted ...
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (allo-iNKT) cell ...
The poster will highlight the key components of the NEPHRO-CRRT study design, currently enrolling patients in the registrational study. There is an unmet medical need for safe, effective, and ...
Spago Nanomedical AB (publ) today announced that an abstract describing the ongoing Phase I/IIa clinical study Tumorad-01 with the radiopharmaceutical drug candidate ¹⁷⁷Lu-SN201 has been accepted for ...
Akari Therapeutics is an oncology biotechnology company developing next-generation antibody drug conjugates (ADCs) with a unique payload, PH1, which targets RNA splicing. Utilizing its innovative ADC ...
The ASCRS Annual Meeting is one of the world’s premier gatherings for ophthalmic surgeons and ophthalmic professionals, showcasing the latest clinical research, surgical techniques, and therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results